Reproposed SALSA Offers Real Chance of Long-Term PAMA Relief
After it failed to pass at the end of 2022, lab leaders and other insiders say they’re optimistic SALSA will pass this year.
After it failed to pass at the end of 2022, lab leaders and other insiders say they’re optimistic SALSA will pass this year.
Congress brings back controversial Trump plan scrapped by the Biden administration.
The bill is designed to provide Medicare patients faster access to innovative technology approved by the FDA.
On March 28, the 118th Congress raised lab industry hopes once more by reintroducing the Saving Access to Laboratory Services Act (SALSA).
It’s not just billions of dollars on the line, but the very future of whistleblower lawsuits and FCA enforcement.